Startup Claims Discovery of ‘1 Generation’ Drug to Rejuvenate Blood
What happened
- A startup named Generation Lab claims to have found a rejuvenation treatment called ‘1 Generation’.
- This treatment is an injectable combination of two existing drugs designed to block the systemic spread of aging in the bloodstream and restore health.
- The company offered access to this treatment to a limited ‘private cohort’ under close physician supervision.
- Insiders reported various benefits, including improved vision, longer sessions, better erections than Viagra, and increased bowel movements.
Why it matters for me
This development stems from the work of founder Irina Conboy, who explored how age characteristics can be transferred between animals via blood exchange (parabiosis). She claims to have found a way to mimic these rejuvenating effects using a combination of existing drugs without needing bodily fluid exchange. While some insiders reported positive results, experts remain skeptical about the evidence and the mechanism behind the treatment.
What to remember
- The specific names of the two drugs used in ‘1 Generation’ are kept confidential by Generation Lab to prevent imitation.
- The company plans a larger study involving one hundred or more people, but some insiders were offered the drug before firm evidence was available.
- Longevity doctors involved in the research expressed mixed feelings, noting enthusiasm alongside skepticism regarding the mechanism and results.
Source: Original article
Source: www.technologyreview.com
